Bicocca Open Archive

Logo unimib boa
VETTORETTI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.577
NA - Nord America 3.440
EU - Europa 1.444
SA - Sud America 913
Continente sconosciuto - Info sul continente non disponibili 263
AF - Africa 103
OC - Oceania 2
Totale 10.742
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.278
SG - Singapore 1.315
VN - Vietnam 875
CN - Cina 829
IT - Italia 678
BR - Brasile 645
HK - Hong Kong 615
BD - Bangladesh 345
RU - Federazione Russa 308
KR - Corea 162
DE - Germania 115
AR - Argentina 110
FR - Francia 102
IN - India 101
CA - Canada 66
IQ - Iraq 53
FI - Finlandia 45
GB - Regno Unito 45
EC - Ecuador 42
ID - Indonesia 41
PK - Pakistan 38
NL - Olanda 37
ZA - Sudafrica 37
CO - Colombia 35
MX - Messico 34
TR - Turchia 34
VE - Venezuela 25
JP - Giappone 22
UZ - Uzbekistan 21
UA - Ucraina 20
MY - Malesia 19
PH - Filippine 19
SE - Svezia 17
AT - Austria 15
CL - Cile 14
PY - Paraguay 14
JM - Giamaica 13
PE - Perù 13
PL - Polonia 13
CR - Costa Rica 12
KE - Kenya 12
SA - Arabia Saudita 12
TN - Tunisia 12
EG - Egitto 10
MA - Marocco 9
UY - Uruguay 9
ET - Etiopia 7
IE - Irlanda 7
KG - Kirghizistan 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
HN - Honduras 6
NP - Nepal 6
AZ - Azerbaigian 5
ES - Italia 5
JO - Giordania 5
KZ - Kazakistan 5
LB - Libano 5
RS - Serbia 5
TH - Thailandia 5
AL - Albania 4
BG - Bulgaria 4
BO - Bolivia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
MM - Myanmar 4
NI - Nicaragua 4
OM - Oman 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
BB - Barbados 3
CI - Costa d'Avorio 3
GT - Guatemala 3
IL - Israele 3
LT - Lituania 3
PA - Panama 3
PS - Palestinian Territory 3
QA - Qatar 3
RO - Romania 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
KH - Cambogia 2
KW - Kuwait 2
PR - Porto Rico 2
SC - Seychelles 2
VG - Isole Vergini Britanniche 2
AM - Armenia 1
BS - Bahamas 1
BT - Bhutan 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
GD - Grenada 1
GR - Grecia 1
GY - Guiana 1
Totale 10.467
Salva come PNG Salva come JPEG
Città #
Singapore 679
Hong Kong 611
San Jose 456
Ashburn 387
Hefei 339
Ho Chi Minh City 269
Hanoi 235
Milan 203
Dallas 167
Seoul 161
Council Bluffs 160
Chicago 110
The Dalles 104
New York 92
Los Angeles 90
Rome 77
Lauterbourg 76
Buffalo 73
Santa Clara 62
Phoenix 59
Boardman 54
Frankfurt am Main 53
São Paulo 53
Moscow 38
Ann Arbor 37
Beijing 28
Figino 28
Turin 28
Da Nang 26
Haiphong 25
Baghdad 23
Seattle 21
Curitiba 20
Denver 19
Biên Hòa 18
Houston 18
Naples 18
Orem 18
Tashkent 18
Lappeenranta 17
Thái Nguyên 17
Brasília 16
Quận Bình Thạnh 16
Quận Một 16
Rio de Janeiro 16
Dhaka 15
Munich 15
Thái Bình 15
Tokyo 15
Washington 15
Helsinki 14
San Francisco 14
Toronto 14
Vũng Tàu 14
Atlanta 13
Brooklyn 13
Can Tho 13
Guayaquil 13
Medellín 13
Mexico City 13
Turku 13
Bologna 12
Ha Long 12
Lahore 12
Montreal 12
Nairobi 12
Quito 12
Wenzhou 12
Belo Horizonte 11
Delhi 11
Jakarta 11
London 11
Miami 11
Salvador 11
Shanghai 11
Amsterdam 10
Campinas 10
Hải Dương 10
Johannesburg 10
Nuremberg 10
Salt Lake City 10
Xiamen 10
Bogotá 9
Erbil 9
Genoa 9
Guangzhou 9
Huế 9
Warsaw 9
Buenos Aires 8
Charlotte 8
Columbus 8
Florence 8
Istanbul 8
Ninh Bình 8
Palermo 8
Phủ Lý 8
São Gonçalo 8
Asunción 7
Caracas 7
Chandler 7
Totale 5.651
Salva come PNG Salva come JPEG
Nome #
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 423
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 315
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial 248
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 213
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy (Journal of Nephrology, (2023), 36, 7, (2013-2022), 10.1007/s40620-023-01708-7) 203
Peritoneal dialysis related peritonitis: insights from a long-term analysis of an Italian center 201
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 193
Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney Disease 191
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: An Italian multicenter prospective study 188
Sarcopenia in Chronic Kidney Disease: Focus on Advanced Glycation End Products as Mediators and Markers of Oxidative Stress 186
Poor Nutritional Status Is Associated with Death in a Population of Dialyzed Older Persons 183
Palliative and Supportive Dialysis: Current Practices and Recommendations for Best Clinical Practice 177
Simultaneous removal and replacement of the peritoneal catheter in CAPD patient with refractory peritonitis sustained by P. aeruginosa: A case-report 174
What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives 167
Relationship between number of daily exchanges at CAPD start with clinical outcomes 165
Spontaneous low-protein intake in older CKD patients: one diet may not fit all 158
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 158
Frailty Is Associated with Malnutrition–Inflammation Syndrome in Older CKD Patients 153
Palliative and supportive dialysis: State of the art and recommendations for good clinical practice 153
Serum uric acid and target organ damage in primary hypertension 152
What's New in the CKD-BMD Therapy? 148
Importance of blood pressure control in chronic kidney disease 147
Corrigendum: Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study (Frontiers in Medicine, (2023), 10, (1221086), 10.3389/fmed.2023.1221086) 145
Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease 143
Clinical Factors and Biomarkers Associated with Depressive Disorders in Older Patients Affected by Chronic Kidney Disease (CKD): Does the Advanced Glycation End Products (AGEs)/RAGE (Receptor for AGEs) System Play Any Role? 142
Association between the uremic toxins indoxyl-sulfate and p-cresyl-sulfate with sarcopenia and malnutrition in elderly patients with advanced chronic kidney disease 137
Possible Benefits of a Low Protein Diet in Older Patients With CKD at Risk of Malnutrition: A Pilot Randomized Controlled Trial 134
Can Mediterranean Diet Have a Positive Impact on Kidney Health? A Pending Answer to a Long-Time Question 133
A new CHA2DS2VASC score integrated with estimated glomerular filtration rate, left ventricular hypertrophy, and pulse pressure is highly effective in predicting adverse cardiovascular outcome in chronic kidney disease 131
Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction 127
Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementation 127
The Number of Medications Is Associated with Fractures in a Population of Dialyzed Older Patients with Frailty 124
Association between Advanced Glycation End-Products and Sarcopenia in Patients with Chronic Kidney Disease 120
Advanced glycation end products (Age) and soluble forms of age receptor: Emerging role as mortality risk factors in CKD 116
MCP1 Could Mediate FGF23 and Omega 6/Omega 3 Correlation Inversion in CKD 115
Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease 115
Nutritional Strategies to Prevent Muscle Loss and Sarcopenia in Chronic Kidney Disease: What Do We Currently Know? 115
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 114
Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress 109
Endothelial dysfunction in chronic kidney disease: Determinant of susceptibility to end-organ damage and therapeutic response 108
The role of angiotensin II AT1 receptor antagonists in nephroprotection and cardioprotection in type 2 diabetes mellitus 106
Vitamin D and Calcium Supplementation and Urolithiasis: A Controversial and Multifaceted Relationship 106
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension 104
Calcium carbonate-enriched cheese to improve nutrition, compliance and phosphorus control in patients on kidney replacement therapy 103
Optimizing global risk evaluation in primary hypertension: The role of microalbuminuria and cardiovascular ultrasonography 103
Frailty phenotype and multi-domain impairments in older patients with chronic kidney disease 103
Beyond cohort selection: An analytics-enabled i2b2 102
Vulvar pyoderma gangrenosum with renal involvement 101
Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: A pilot study 101
Microalbuminuria, cardiovascular, and renal risk in primary hypertension 99
Frailty index and adverse outcomes in older patients in haemodialysis 99
Plasma adiponectin levels in chronic kidney disease patients: Relation with molecular inflammatory profile and metabolic status 99
Economic evaluation of angiotensin receptor blockers in type 2 diabetes, hypertension, and nephropathy 98
Use of the Frailty Index in Older Persons With Chronic Kidney Disease 97
Mild renal dysfunction and renal vascular resistance in primary hypertension 94
Pulse pressure and subclinical cardiovascular damage in primary hypertension 94
Vitamin D and subclinical cardiac damage in a cohort of kidney transplanted patients: a retrospective observational study 93
Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study 93
Mild Renal Dysfunction and Cardiovascular Risk in Hypertensive Patients 92
Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized rats 92
Metabolic acidosis in renal transplantation: neglected but of potential clinical relevance 91
Patients with Hypertensive Nephropathy and Chronic Kidney Disease Might Not Benefit from Strict Blood Pressure Control 91
Changes over time in ambulatory blood pressure and cardiac parameters predict cardiovascular outcome of patients with CKD and low cardiovascular morbidity 91
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 91
In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition 90
MCP1 Inverts the Correlation between FGF23 and Omega 6/3 Ratio: Is It Also True in Renal Transplantation? 90
Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation 90
Is there an association between severity of illness and psychiatric symptoms in patients with chronic renal failure? 89
Association of Autofluorescent Advanced Glycation End Products (AGEs) with Frailty Components in Chronic Kidney Disease (CKD): Data from a Single-Center Cohort Study 89
Malnutrition and inflammation are associated with severity of depressive and cognitive symptoms of old patients affected by chronic kidney disease 88
Associations Between Cholesterol and Fatty Acid Profile on the Severity of Depression in Older Persons With Nondialysis Chronic Kidney Disease 86
Frailty in kidney transplantation: a review on its evaluation, variation and long-term impact 86
Treatment of hyperuricemia in CKD 86
Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice 85
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 84
Sarcopenia is associated with malnutrition but not with systemic inflammation in older persons with advanced CKD 84
AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease 84
The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism 83
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: An artificial neural network-based approach 83
Renal and cardiovascular protection in type 2 diabetes mellitus: Angiotensin II receptor blockers 82
Prevention and treatment of diabetic nephropathy: The program for Irbesartan mortality and morbidity evaluation 81
Renal endothelial function is associated with the anti-proteinuric effect of ACE inhibition in 5/6 nephrectomized rats 81
Creatinine clearance and signs of end-organ damage in primary hypertension 79
Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension 79
Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension 75
Cardiovascular and Renal Risk Assessment as a Guide for Treatment in Primary Hypertension 74
Totale 10.742
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.191
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202219 0 0 6 2 1 5 0 0 2 0 1 2
2022/202357 5 14 9 8 9 7 0 0 2 1 0 2
2023/202414 1 2 2 1 0 5 0 0 2 0 0 1
2024/20252.461 1 6 2 2 3 1 15 4 558 541 331 997
2025/20266.555 574 790 606 892 361 246 576 352 547 443 354 814
2026/20271.564 400 484 680 0 0 0 0 0 0 0 0 0
Totale 10.742